Yarrow Bioscience, Inc. (YARW)
Data as of , from SEC Form 4 filings.
See up to 3 months of YARW. The 7-day demo opens the 1M and 3M ranges and puts YARW on your watchlist.
Start 7-day demoLatest YARW insider trades
About Yarrow Bioscience, Inc. (YARW)
Yarrow Bioscience, Inc. is an SEC registrant, filing under CIK 0001566044, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
YARW Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 5 | 924,780 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
YARW insider transactions (Form 4)
3140 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 1 of 2.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Lori Payton - Officer | Grant or award | Stock Option (Right to Buy) | 99,827 | $0.00 | - | |
| Rachael Alford - Officer | Grant or award | Stock Option (Right to Buy) | 89,844 | $0.00 | - | |
| Rebecca Frey - Officer | Grant or award | Stock Option (Right to Buy) | 465,857 | $0.00 | - | |
| Steven Ryder - Officer | Grant or award | Stock Option (Right to Buy) | 113,137 | $0.00 | - | |
 Tyler Zeronda - Officer | Grant or award | Stock Option (Right to Buy) | 156,115 | $0.00 | - | |
| RTW Fund Group GP, LLC - 10% Owner | Other | Common Stock | 133,290 | $0.00 | - | |
| RTW Fund Group GP, LLC - 10% Owner | Other | Pre-Funded Warrants (Right to Buy) | 133,290 | $0.00 | - | |
| Mona Ashiya - Director | Grant or award | Stock Option (Right to Buy) | 15,435 | $0.00 | - | |
| Tyler Zeronda - Director | Grant or award | Stock Option (Right to Buy) | 185,798 | $0.00 | - | |
| Tyler Zeronda - Officer | Tax withholding / forfeiture | Common Stock | 22,516 | $0.90 | $20K | |
 Iain Stuart - Officer | Tax withholding / forfeiture | Common Stock | 15,405 | $0.90 | $14K | |
| Mutya Harsch - Officer | Tax withholding / forfeiture | Common Stock | 22,516 | $0.90 | $20K | |
| David Domzalski - Officer | Tax withholding / forfeiture | Common Stock | 79,391 | $0.90 | $71K | |
| Tyler Zeronda - Officer | Tax withholding / forfeiture | Common Stock | 3,464 | $0.65 | $2K | |
| Iain Stuart - Officer | Tax withholding / forfeiture | Common Stock | 2,370 | $0.65 | $2K | |
| Mutya Harsch - Officer | Tax withholding / forfeiture | Common Stock | 3,464 | $0.65 | $2K | |
| David Domzalski - Officer | Tax withholding / forfeiture | Common Stock | 12,214 | $0.65 | $8K | |
| David Domzalski - Officer | Grant or award | Common Stock | 30,791 | $0.31 | $10K | |
| Tyler Zeronda - Officer | Tax withholding / forfeiture | Common Stock | 4,007 | $0.60 | $2K | |
| Iain Stuart - Officer | Tax withholding / forfeiture | Common Stock | 2,876 | $0.60 | $2K | |
| Mutya Harsch - Officer | Tax withholding / forfeiture | Common Stock | 4,007 | $0.60 | $2K | |
| David Domzalski - Officer | Tax withholding / forfeiture | Common Stock | 14,232 | $0.60 | $9K | |
| Tyler Zeronda - Officer | Tax withholding / forfeiture | Common Stock | 3,420 | $0.34 | $1K | |
| Mutya Harsch - Officer | Tax withholding / forfeiture | Common Stock | 3,581 | $0.34 | $1K | |
| David Domzalski - Officer | Tax withholding / forfeiture | Common Stock | 12,676 | $0.34 | $4K | |
| Iain Stuart - Officer | Tax withholding / forfeiture | Common Stock | 2,453 | $0.34 | $822 | |
| Tyler Zeronda - Officer | Tax withholding / forfeiture | Common Stock | 3,420 | $1.65 | $6K | |
| Iain Stuart - Officer | Tax withholding / forfeiture | Common Stock | 2,453 | $1.65 | $4K | |
| Mutya Harsch - Officer | Tax withholding / forfeiture | Common Stock | 3,581 | $1.65 | $6K | |
| David Domzalski - Officer | Tax withholding / forfeiture | Common Stock | 12,676 | $1.65 | $21K | |
| Christine Borowski | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - |
YARW insider trading FAQ
What is the latest insider trade for YARW?
Yarrow Bioscience, Inc. (YARW) had 5 insider filings in the last 90 days, with the most recent on 30 October 2026. The full record for YARW runs to 40 Form 4 filings, the earliest from 2 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying YARW stock?
No insider purchases of YARW were filed in the last 90 days.
How many insiders are selling YARW stock?
No insider sales of YARW were filed in the last 90 days.
Where can I see YARW SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects YARW Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Lori Payton view on EDGAR
- - Rachael Alford view on EDGAR
- - Rebecca Frey view on EDGAR
- - Steven Ryder view on EDGAR
- - Tyler Zeronda view on EDGAR
- - RTW Fund Group GP, LLC view on EDGAR
- - Mona Ashiya view on EDGAR
- - Tyler Zeronda view on EDGAR
- - Tyler Zeronda view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where YARW's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow YARW with a 7-day demo
- YARW on your watchlist
- Every YARW Form 4 filing on record
- Up to 3 months of YARW price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
